Ceresetto J, Bottaro F. Idarucizumab: reversal agent for dabigatrán. RH [Internet]. 2019 Jan. 21 [cited 2026 Nov. 9];22(3):315-21. Available from: https://revistahematologia.com.ar/index.php/Revista/article/view/46